XBI ETF
State Street SPDR S&P Biotech ETF
MRNA is XBI's largest holding at 3.04% of the fund as of Sep 11, 2026. XBI is State Street SPDR S&P Biotech ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Share chg | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | — | Moderna therapeuticsHealth Care · Biotechnology | 3.04% | 3.0% | 2,266,461 | +5.4K | Health Care | Biotechnology |
| 2 | T | Twist Bioscience Corp.Health Care · Biotechnology | 1.82% | 4.9% | 1,538,121 | +3.8K | Health Care | Biotechnology |
| Share changes, sector and industry · Pro | ||||||||
| 3 | N | Natera Inc | 1.48% | 6.3% | 481,504 | |||
| 4 | H | Halozyme Therapeutics Inc | 1.48% | 7.8% | 1,478,512 | |||
| 5 | K | Kymera Therapeutics Inc | 1.43% | 9.3% | 1,332,435 | |||
| 6 | O | Oruka Therapeutics Inc Orka | 1.40% | 10.7% | 1,627,933 | |||
| 7 | — | Roivant Sciences Ltd. Common Shares | 1.39% | 12.0% | 3,668,940 | |||
| 8 | R | Revolution Medicines Inc | 1.37% | 13.4% | 722,883 | |||
| 9 | T | Travere Therapeutics Inc | 1.37% | 14.8% | 2,230,138 | |||
| 10 | I | Insmed Inc | 1.37% | 16.2% | 1,134,475 | |||
| 11 | P | Protagonist Therapeutics Inc | 1.36% | 17.5% | 985,454 | |||
| 12 | P | Praxis Precision Medicines, Inc. | 1.35% | 18.9% | 433,123 | |||
| 13 | D | Dianthus Therapeutics Inc | 1.35% | 20.2% | 1,363,932 | |||
| 14 | C | Cg Oncology Inc | 1.28% | 21.5% | 1,897,916 | |||
| 15 | S | Summit Therapeutics | 1.28% | 22.8% | 7,802,291 | |||
| 16 | P | Vaxcyte Inc | 1.27% | 24.0% | 2,294,890 | |||
| 17 | R | Regeneron Pharmaceuticals, Inc. | 1.26% | 25.3% | 173,267 | |||
| 18 | S | Scholar Rock Holding Corp | 1.22% | 26.5% | 2,364,112 | |||
| 19 | I | Iovance Biotherapeutics Inc | 1.22% | 27.7% | 15,213,061 | |||
| 20 | R | Rhythm Pharmaceuticals Inc | 1.19% | 28.9% | 1,216,099 | |||
| 21 | S | Spyre Therapeutics Inc | 1.17% | 30.1% | 1,388,292 | |||
| 22 | R | Relay Therapeutics Inc | 1.16% | 31.3% | 6,600,041 | |||
| 23 | — | Nvaesrtex Pharmaceuticals Inc | 1.15% | 32.4% | 239,225 | |||
| 24 | E | Erasca Inc. | 1.15% | 33.6% | 7,796,179 | |||
| 25 | G | Gilead Sciences | 1.15% | 34.7% | 857,995 | |||
| 26 | A | Arrowhead Pharmaceuticals Inc | 1.14% | 35.9% | 1,473,669 | |||
| 27 | B | Biomarin Pharmaceutical Inc. | 1.14% | 37.0% | 1,855,711 | |||
| 28 | I | Incyte Corp. | 1.12% | 38.1% | 989,045 | |||
| 29 | T | Tg Therapeutics Inc | 1.12% | 39.2% | 2,235,852 | |||
| 30 | V | Viking Therapeutics Inc | 1.12% | 40.4% | 3,756,271 | |||
| 31 | A | AbbVie Inc. | 1.11% | 41.5% | 463,374 | |||
| 32 | M | Madrigal Pharmaceuticals Inc | 1.10% | 42.6% | 221,136 | |||
| 33 | B | Biogen Inc. | 1.09% | 43.7% | 536,652 | |||
| 34 | A | Acadia Pharmaceuticals Inc | 1.08% | 44.7% | 4,163,340 | |||
| 35 | A | Amgen Inc. | 1.08% | 45.8% | 308,673 | |||
| 36 | K | Krystal Biotech Inc | 1.08% | 46.9% | 333,631 | |||
| 37 | C | Cytokinetics Inc | 1.07% | 48.0% | 1,554,092 | |||
| 38 | G | Grail, Inc. | 1.06% | 49.0% | 1,492,269 | |||
| 39 | B | Bridgebio Pharma Inc_None_0 | 1.04% | 50.1% | 1,546,399 | |||
| 40 | E | Exelixis Inc | 1.04% | 51.1% | 1,982,412 | |||
| 41 | — | Uniqure N.V. Ordinary Shares | 1.04% | 52.1% | 2,508,740 | |||
| 42 | C | Cogent Biosciences Inc | 1.03% | 53.2% | 3,321,707 | |||
| 43 | — | Alkermes Plc. Ordinary Shares | 1.02% | 54.2% | 2,377,656 | |||
| 44 | — | Crispr Therapeutics Ag Common Shares | 1.02% | 55.2% | 2,108,354 | |||
| 45 | M | Mirum Pharmaceuticals, Inc. | 1.01% | 56.2% | 1,108,833 | |||
| 46 | S | Sellas Life Sciences Group Inc. | 0.97% | 57.2% | 9,058,437 | |||
| 47 | I | Immunitybio Inc | 0.96% | 58.2% | 13,080,843 | |||
| 48 | I | Immunovant Inc | 0.94% | 59.1% | 2,697,344 | |||
| 49 | N | Neurocrine Biosciences Inc | 0.94% | 60.0% | 647,967 | |||
| 50 | C | Celcuity Inc | 0.92% | 61.0% | 1,181,311 | |||
| More holdings · Pro | ||||||||
XBI ETF All Holdings
XBI holdings total 313 positions. The top 10 holdings account for 16.2% of the fund, led by Moderna therapeutics at 3.0%, Twist Bioscience Corp. at 1.8%, Natera Inc at 1.5%.
XBI portfolio concentration is well-diversified, with the top 10 representing 16.2% of total assets. The largest sector exposure is Health Care at 97.7%.
XBI sectors provide a detailed breakdown. XBI overlap shows how holdings compare to other funds in your portfolio.
XBI ETF Holdings
156 of 313 holdings
- 1
Moderna therapeutics
MRNAHealth Care3.04% - 2
Twist Bioscience Corp.
TWSTHealth Care1.82% - 3
Natera Inc
NTRAHealth Care1.48% - 4
Halozyme Therapeutics Inc
HALOHealth Care1.48% - 5
Kymera Therapeutics Inc
KYMRHealth Care1.43% - 6
Oruka Therapeutics Inc Orka
ORKAHealth Care1.40% - 7
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care1.39% - 8
Revolution Medicines Inc
RVMDHealth Care1.37% - 9
Travere Therapeutics Inc
TVTXHealth Care1.37% - 10
Insmed Inc
INSMHealth Care1.37% - 11
Protagonist Therapeutics Inc
PTGXHealth Care1.36% - 12
Praxis Precision Medicines, Inc.
PRAXHealth Care1.35% - 13
Dianthus Therapeutics Inc
DNTHHealth Care1.35% - 14
Cg Oncology Inc
CGONHealth Care1.28% - 15
Summit Therapeutics
SMMTHealth Care1.28% - 16
Vaxcyte Inc
PCVXHealth Care1.27% - 17
Regeneron Pharmaceuticals, Inc.
REGNHealth Care1.26% - 18
Scholar Rock Holding Corporation Com
SRRKHealth Care1.22% - 19
Iovance Biotherapeutics Inc
IOVAHealth Care1.22% - 20
Rhythm Pharmaceuticals Inc
RYTMHealth Care1.19% - 21
Spyre Therapeutics Inc
SYREHealth Care1.17% - 22
Relay Therapeutics Inc
RLAYHealth Care1.16% - 23
Nvaesrtex Pharmaceuticals Inc
VRTXHealth Care1.15% - 24
Erasca Inc.
ERASHealth Care1.15% - 25
Gilead Sciences
GILDHealth Care1.15% - 26
Arrowhead Pharmaceuticals Inc
ARWRHealth Care1.14% - 27
Biomarin Pharmaceutical Inc.
BMRNHealth Care1.14% - 28
Incyte Corp.
INCYHealth Care1.12% - 29
Tg Therapeutics Inc Common Stock
TGTXHealth Care1.12% - 30
Viking Therapeutics Inc Com
VKTXHealth Care1.12% - 31
Abbvie Inc.
ABBVHealth Care1.11% - 32
Madrigal Pharmaceuticals Inc
MDGLHealth Care1.10% - 33
Biogen Inc. Com
BIIBHealth Care1.09% - 34
Acadia Pharmaceuticals Inc Common Stock Usd 0.0001
ACADHealth Care1.08% - 35
Amgen Inc.
AMGNHealth Care1.08% - 36
Krystal Biotech Inc
KRYSHealth Care1.08% - 37
Cytokinetics Inc
CYTKHealth Care1.07% - 38
Grail, Inc.
GRALHealth Care1.06% - 39
Bridgebio Pharma Inc_None_0
BBIOHealth Care1.04% - 40
Exelixis Inc
EXELHealth Care1.04% - 41
Uniqure N.V. Ordinary Shares
QURE:ASHealth Care1.04% - 42
Cogent Biosciences Inc
COGTHealth Care1.03% - 43
Alkermes Plc. Ordinary Shares
ALKS:IEHealth Care1.02% - 44
Crispr Therapeutics Ag Common Shares
CRSP:SMHealth Care1.02% - 45
Mirum Pharmaceuticals, Inc.
MIRMHealth Care1.01% - 46
Sellas Life Sciences Group Inc.
SLSHealth Care0.97% - 47
Immunitybio Inc
IBRXHealth Care0.96% - 48
Immunovant Inc
IMVTHealth Care0.94% - 49
Neurocrine Biosciences Inc
NBIXHealth Care0.94% - 50
Celcuity Inc Com
CELCHealth Care0.92% - 51
Vera Therapeutics Inc Ser C Pc Pp
VERAHealth Care0.91% - 52
Sarepta Therapeutics Inc
SRPTHealth Care0.89% - 53
United Therapeutics Corp
UTHRHealth Care0.89% - 54
Ptc Therapeutics Inc
PTCTHealth Care0.87% - 55
Ideaya Biosciences Inc
IDYAHealth Care0.85% - 56
Alnylam Pharmaceuticals Inc.
ALNYHealth Care0.83% - 57
Viridian Therapeutics Ors Inc
VRDNHealth Care0.81% - 58
Beam Therapeutics Inc. Com
BEAMHealth Care0.79% - 59
Mineralys Therapeutics Inc
MLYSHealth Care0.78% - 60
BioCryst Pharmaceuticals Inc.
BCRXHealth Care0.76% - 61
Dynegy
DYNHealth Care0.74% - 62
Celldex Therapeutics Inc
CLDXHealth Care0.73% - 63
Hyperliquid Strategies Inc
PURRUnknown0.72% - 64
Immunome Inc
IMNMHealth Care0.72% - 65
Ionis Pharmaceuticals Inc
IONSHealth Care0.72% - 66
Denali Therapeutics Inc
DNLIHealth Care0.71% - 67
Adma Biologics Inc Com
ADMAHealth Care0.70% - 68
Novavax Inc
NVAXHealth Care0.69% - 69
Recursion Pharmaceuticals Inc
RXRXHealth Care0.69% - 70
Arcutis Biotherapeutics Inc
ARQTHealth Care0.68% - 71
Tango Therapeutics Inc.
TNGXHealth Care0.67% - 72
Agios Pharmaceuticals Inc
AGIOHealth Care0.66% - 73
Intellia Therapeutics Inc
NTLAHealth Care0.66% - 74
Disc Medicine, Inc.
IRONHealth Care0.65% - 75
Syndax Pharmaceuticals Inc
SNDXHealth Care0.63% - 76
Arcus Biosciences Inc
RCUSHealth Care0.62% - 77
Nurix Therapeutics Inc Common Stock
NRIXHealth Care0.60% - 78
Palvella Therapeutics Inc
PVLAHealth Care0.60% - 79
Veracyte, Inc.
VCYTHealth Care0.60% - 80
Caredx Inc
CDNAHealth Care0.56% - 81
Ultragenyx Pharmaceutical Inc
RAREHealth Care0.51% - 82
Vir Biotechnology Inc.
VIRHealth Care0.51% - 83
Kodiak Sciences Inc
KODHealth Care0.48% - 84
Cullinan Oncology Inc
CGEMHealth Care0.48% - 85
Precigen Corp
PGENHealth Care0.47% - 86
Biohaven Ltd
BHVNUnknown0.47% - 87
Xencor Inc
XNCRHealth Care0.46% - 88
Stoke Therapeutics Inc Com
STOKHealth Care0.45% - 89
Vericel Corp
VCELHealth Care0.45% - 90
Inhibrx Biosciences Inc
INBXHealth Care0.43% - 91
Absci Corp
ABSIHealth Care0.42% - 92
Anaptysbio Inc
ANABHealth Care0.41% - 93
Zenas Biopharma Inc
ZBIOHealth Care0.41% - 94
Oric Pharmaceuticals, Inc. Series C
ORICHealth Care0.38% - 95
Vor Biopharma Inc
VORHealth Care0.38% - 96
Corvus Pharmaceuticals Inc
CRVSHealth Care0.37% - 97
Replimune Group Inc Com
REPLHealth Care0.35% - 98
Kura Oncology Inc
KURAHealth Care0.34% - 99
First Tracks Biotherapeutics, Inc.
TRAXUnknown0.33% - 100
Avalo Therapeuti
AVTXHealth Care0.32% - 101
Janux Therapeutics Inc
JANXHealth Care0.32% - 102
Mannkind Corporation Com New
MNKDHealth Care0.31% - 103
Rigel Pharmaceuticals Inc
RIGLUnknown0.30% - 104
Tyra Biosciences Inc
TYRAHealth Care0.30% - 105
Monte Rosa Therapeutics Inc
GLUEHealth Care0.29% - 106
Geron Corp
GERNHealth Care0.29% - 107
Jade Biosciences Inc
JBIOHealth Care0.27% - 108
Olema Pharmaceuticals Inc
OLMAHealth Care0.27% - 109
Taysha Gene Therapies Inc
TSHAHealth Care0.27% - 110
Altimmune Inc
ALTHealth Care0.26% - 111
Ardelyx Inc
ARDXHealth Care0.26% - 112
Cytomx Therapeutics Inc
CTMXHealth Care0.26% - 113
ARRIVENT BIOPHARMA INC
AVBPHealth Care0.25% - 114
Immix Biopharma Inc
IMMXHealth Care0.25% - 115
Annexon Inc
ANNXHealth Care0.24% - 116
Bicara Therapeutics, Inc.
BCAXHealth Care0.24% - 117
Verastem Inc
VSTMUnknown0.24% - 118
Sana Biotechnology Inc
SANAHealth Care0.22% - 119
Solid Biosciences Inc
SLDBHealth Care0.22% - 120
Ironwood Pharmaceuticals Inc
IRWDHealth Care0.22% - 121
Allogene Therapeutics Inc
ALLOHealth Care0.21% - 122
Candel Therapeutics Inc.
CADLHealth Care0.21% - 123
4d Molecular Therapeutics Inc.
FDMTHealth Care0.21% - 124
Damora Therapeutics, Inc.
DMRAHealth Care0.20% - 125
Arbutus Biopharma Corp.
ABUSHealth Care0.18% - 126
Capricor Therapeutics Inc
CAPRHealth Care0.18% - 127
Savara Inc
SVRAHealth Care0.17% - 128
Prime Medicine, Inc.
PRMEHealth Care0.16% - 129
Regenxbio Inc
RGNXHealth Care0.16% - 130
Ocugen Inc.
OCGNHealth Care0.14% - 131
Cabaletta Bio Inc
CABAHealth Care0.14% - 132
COMPASS THERAPEUTICS INC
CMPXHealth Care0.13% - 133
Mimedx Group Inc Com
MDXGHealth Care0.13% - 134
Ovid Therapeutics Inc
OVIDHealth Care0.13% - 135
Prothena Corporation Public Limited Company Ordinary Shares
PRTA:IEHealth Care0.13% - 136
ARS Pharmaceuticals Inc
SPRYHealth Care0.11% - 137
Vanda Pharmaceuticals Inc
VNDAHealth Care0.11% - 138
Perspective Ther
CATXHealth Care0.11% - 139
Emergent Biosolutions Inc
EBSHealth Care0.10% - 140
Lexeo Therapeutics Inc - Series B
LEXOHealth Care0.10% - 141
Myriad Genetics, Inc.
MYGNHealth Care0.10% - 142
Sagimet Biosciences Inc
SGMTHealth Care0.10% - 143
Ssi Us Gov Money Market Class
GVMXXUnknown0.10% - 144
Achieve Life Sciences Inc
ACHVHealth Care0.09% - 145
Contra Metsera Inc
Other0.07% - 146
Maplight Therapeutics Inc
MPLTUnknown0.06% - 147
Sionna Therapeutics Inc
SIONHealth Care0.05% - 148
BRIDGEBIO ONCOLOGY THERAPEUTICS IN
BBOTUnknown0.04% - 149
Contra Akero Therapeut Common Stock
Other0.01% - 150
Ping An Insu Ran Ce Group Co. Of C Hin A Ltd.
601318:SHHealth Care0.01% - 151
Contra Inhibrx Inc
Other0.01% - 152
Contra Verve Therapeut
Other0.01% - 153
Omniab Inc 12.5 Earnout
OABIHealth Care0.00% - 154
Omniab Inc 15.00 Earnout
OABIHealth Care0.00% - 155
us dollar001/00/1900
Other0.00% - 156
Contra Blueprint Medic
Health Care0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Moderna therapeutics | MRNA | 3.040% | ||
| 2 | Twist Bioscience Corp. | TWST | 1.820% | ||
| 3 | Natera Inc | NTRA | 1.480% | ||
| 4 | Halozyme Therapeutics Inc | HALO | 1.480% | ||
| 5 | Kymera Therapeutics Inc | KYMR | 1.430% | ||
| 6 | Oruka Therapeutics Inc Orka | ORKA | 1.400% | ||
| 7 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 1.390% | ||
| 8 | Revolution Medicines Inc | RVMD | 1.370% | ||
| 9 | Travere Therapeutics Inc | TVTX | 1.370% | ||
| 10 | Insmed Inc | INSM | 1.370% | ||
| 11 | Protagonist Therapeutics Inc | PTGX | 1.360% | ||
| 12 | Praxis Precision Medicines, Inc. | PRAX | 1.350% | ||
| 13 | Dianthus Therapeutics Inc | DNTH | 1.350% | ||
| 14 | Cg Oncology Inc | CGON | 1.280% | ||
| 15 | Summit Therapeutics | SMMT | 1.280% | ||
| 16 | Vaxcyte Inc | PCVX | 1.270% | ||
| 17 | Regeneron Pharmaceuticals, Inc. | REGN | 1.260% | ||
| 18 | Scholar Rock Holding Corporation Com | SRRK | 1.220% | ||
| 19 | Iovance Biotherapeutics Inc | IOVA | 1.220% | ||
| 20 | Rhythm Pharmaceuticals Inc | RYTM | 1.190% | ||
| 21 | Spyre Therapeutics Inc | SYRE | 1.170% | ||
| 22 | Relay Therapeutics Inc | RLAY | 1.160% | ||
| 23 | Nvaesrtex Pharmaceuticals Inc | VRTX | 1.150% | ||
| 24 | Erasca Inc. | ERAS | 1.150% | ||
| 25 | Gilead Sciences | GILD | 1.150% | ||
| 26 | Arrowhead Pharmaceuticals Inc | ARWR | 1.140% | ||
| 27 | Biomarin Pharmaceutical Inc. | BMRN | 1.140% | ||
| 28 | Incyte Corp. | INCY | 1.120% | ||
| 29 | Tg Therapeutics Inc Common Stock | TGTX | 1.120% | ||
| 30 | Viking Therapeutics Inc Com | VKTX | 1.120% | ||
| 31 | Abbvie Inc. | ABBV | 1.110% | ||
| 32 | Madrigal Pharmaceuticals Inc | MDGL | 1.100% | ||
| 33 | Biogen Inc. Com | BIIB | 1.090% | ||
| 34 | Acadia Pharmaceuticals Inc Common Stock Usd 0.0001 | ACAD | 1.080% | ||
| 35 | Amgen Inc. | AMGN | 1.080% | ||
| 36 | Krystal Biotech Inc | KRYS | 1.080% | ||
| 37 | Cytokinetics Inc | CYTK | 1.070% | ||
| 38 | Grail, Inc. | GRAL | 1.060% | ||
| 39 | Bridgebio Pharma Inc_None_0 | BBIO | 1.040% | ||
| 40 | Exelixis Inc | EXEL | 1.040% | ||
| 41 | Uniqure N.V. Ordinary Shares | QURE:AS | 1.040% | ||
| 42 | Cogent Biosciences Inc | COGT | 1.030% | ||
| 43 | Alkermes Plc. Ordinary Shares | ALKS:IE | 1.020% | ||
| 44 | Crispr Therapeutics Ag Common Shares | CRSP:SM | 1.020% | ||
| 45 | Mirum Pharmaceuticals, Inc. | MIRM | 1.010% | ||
| 46 | Sellas Life Sciences Group Inc. | SLS | 0.970% | ||
| 47 | Immunitybio Inc | IBRX | 0.960% | ||
| 48 | Immunovant Inc | IMVT | 0.940% | ||
| 49 | Neurocrine Biosciences Inc | NBIX | 0.940% | ||
| 50 | Celcuity Inc Com | CELC | 0.920% | ||
| 51 | Vera Therapeutics Inc Ser C Pc Pp | VERA | 0.910% | ||
| 52 | Sarepta Therapeutics Inc | SRPT | 0.890% | ||
| 53 | United Therapeutics Corp | UTHR | 0.890% | ||
| 54 | Ptc Therapeutics Inc | PTCT | 0.870% | ||
| 55 | Ideaya Biosciences Inc | IDYA | 0.850% | ||
| 56 | Alnylam Pharmaceuticals Inc. | ALNY | 0.830% | ||
| 57 | Viridian Therapeutics Ors Inc | VRDN | 0.810% | ||
| 58 | Beam Therapeutics Inc. Com | BEAM | 0.790% | ||
| 59 | Mineralys Therapeutics Inc | MLYS | 0.780% | ||
| 60 | BioCryst Pharmaceuticals Inc. | BCRX | 0.760% | ||
| 61 | Dynegy | DYN | 0.740% | ||
| 62 | Celldex Therapeutics Inc | CLDX | 0.730% | ||
| 63 | Hyperliquid Strategies Inc | PURR | 0.720% | ||
| 64 | Immunome Inc | IMNM | 0.720% | ||
| 65 | Ionis Pharmaceuticals Inc | IONS | 0.720% | ||
| 66 | Denali Therapeutics Inc | DNLI | 0.710% | ||
| 67 | Adma Biologics Inc Com | ADMA | 0.700% | ||
| 68 | Novavax Inc | NVAX | 0.690% | ||
| 69 | Recursion Pharmaceuticals Inc | RXRX | 0.690% | ||
| 70 | Arcutis Biotherapeutics Inc | ARQT | 0.680% | ||
| 71 | Tango Therapeutics Inc. | TNGX | 0.670% | ||
| 72 | Agios Pharmaceuticals Inc | AGIO | 0.660% | ||
| 73 | Intellia Therapeutics Inc | NTLA | 0.660% | ||
| 74 | Disc Medicine, Inc. | IRON | 0.650% | ||
| 75 | Syndax Pharmaceuticals Inc | SNDX | 0.630% | ||
| 76 | Arcus Biosciences Inc | RCUS | 0.620% | ||
| 77 | Nurix Therapeutics Inc Common Stock | NRIX | 0.600% | ||
| 78 | Palvella Therapeutics Inc | PVLA | 0.600% | ||
| 79 | Veracyte, Inc. | VCYT | 0.600% | ||
| 80 | Caredx Inc | CDNA | 0.560% | ||
| 81 | Ultragenyx Pharmaceutical Inc | RARE | 0.510% | ||
| 82 | Vir Biotechnology Inc. | VIR | 0.510% | ||
| 83 | Kodiak Sciences Inc | KOD | 0.480% | ||
| 84 | Cullinan Oncology Inc | CGEM | 0.480% | ||
| 85 | Precigen Corp | PGEN | 0.470% | ||
| 86 | Biohaven Ltd | BHVN | 0.470% | ||
| 87 | Xencor Inc | XNCR | 0.460% | ||
| 88 | Stoke Therapeutics Inc Com | STOK | 0.450% | ||
| 89 | Vericel Corp | VCEL | 0.450% | ||
| 90 | Inhibrx Biosciences Inc | INBX | 0.430% | ||
| 91 | Absci Corp | ABSI | 0.420% | ||
| 92 | Anaptysbio Inc | ANAB | 0.410% | ||
| 93 | Zenas Biopharma Inc | ZBIO | 0.410% | ||
| 94 | Oric Pharmaceuticals, Inc. Series C | ORIC | 0.380% | ||
| 95 | Vor Biopharma Inc | VOR | 0.380% | ||
| 96 | Corvus Pharmaceuticals Inc | CRVS | 0.370% | ||
| 97 | Replimune Group Inc Com | REPL | 0.350% | ||
| 98 | Kura Oncology Inc | KURA | 0.340% | ||
| 99 | First Tracks Biotherapeutics, Inc. | TRAX | 0.330% | ||
| 100 | Avalo Therapeuti | AVTX | 0.320% | ||
| 101 | Janux Therapeutics Inc | JANX | 0.320% | ||
| 102 | Mannkind Corporation Com New | MNKD | 0.310% | ||
| 103 | Rigel Pharmaceuticals Inc | RIGL | 0.300% | ||
| 104 | Tyra Biosciences Inc | TYRA | 0.300% | ||
| 105 | Monte Rosa Therapeutics Inc | GLUE | 0.290% | ||
| 106 | Geron Corp | GERN | 0.290% | ||
| 107 | Jade Biosciences Inc | JBIO | 0.270% | ||
| 108 | Olema Pharmaceuticals Inc | OLMA | 0.270% | ||
| 109 | Taysha Gene Therapies Inc | TSHA | 0.270% | ||
| 110 | Altimmune Inc | ALT | 0.260% | ||
| 111 | Ardelyx Inc | ARDX | 0.260% | ||
| 112 | Cytomx Therapeutics Inc | CTMX | 0.260% | ||
| 113 | ARRIVENT BIOPHARMA INC | AVBP | 0.250% | ||
| 114 | Immix Biopharma Inc | IMMX | 0.250% | ||
| 115 | Annexon Inc | ANNX | 0.240% | ||
| 116 | Bicara Therapeutics, Inc. | BCAX | 0.240% | ||
| 117 | Verastem Inc | VSTM | 0.240% | ||
| 118 | Sana Biotechnology Inc | SANA | 0.220% | ||
| 119 | Solid Biosciences Inc | SLDB | 0.220% | ||
| 120 | Ironwood Pharmaceuticals Inc | IRWD | 0.220% | ||
| 121 | Allogene Therapeutics Inc | ALLO | 0.210% | ||
| 122 | Candel Therapeutics Inc. | CADL | 0.210% | ||
| 123 | 4d Molecular Therapeutics Inc. | FDMT | 0.210% | ||
| 124 | Damora Therapeutics, Inc. | DMRA | 0.200% | ||
| 125 | Arbutus Biopharma Corp. | ABUS | 0.180% | ||
| 126 | Capricor Therapeutics Inc | CAPR | 0.180% | ||
| 127 | Savara Inc | SVRA | 0.170% | ||
| 128 | Prime Medicine, Inc. | PRME | 0.160% | ||
| 129 | Regenxbio Inc | RGNX | 0.160% | ||
| 130 | Ocugen Inc. | OCGN | 0.140% | ||
| 131 | Cabaletta Bio Inc | CABA | 0.140% | ||
| 132 | COMPASS THERAPEUTICS INC | CMPX | 0.130% | ||
| 133 | Mimedx Group Inc Com | MDXG | 0.130% | ||
| 134 | Ovid Therapeutics Inc | OVID | 0.130% | ||
| 135 | Prothena Corporation Public Limited Company Ordinary Shares | PRTA:IE | 0.130% | ||
| 136 | ARS Pharmaceuticals Inc | SPRY | 0.110% | ||
| 137 | Vanda Pharmaceuticals Inc | VNDA | 0.110% | ||
| 138 | Perspective Ther | CATX | 0.110% | ||
| 139 | Emergent Biosolutions Inc | EBS | 0.100% | ||
| 140 | Lexeo Therapeutics Inc - Series B | LEXO | 0.100% | ||
| 141 | Myriad Genetics, Inc. | MYGN | 0.100% | ||
| 142 | Sagimet Biosciences Inc | SGMT | 0.100% | ||
| 143 | Ssi Us Gov Money Market Class | GVMXX | 0.100% | ||
| 144 | Achieve Life Sciences Inc | ACHV | 0.090% | ||
| 145 | Contra Metsera Inc | - | 0.070% | ||
| 146 | Maplight Therapeutics Inc | MPLT | 0.060% | ||
| 147 | Sionna Therapeutics Inc | SION | 0.050% | ||
| 148 | BRIDGEBIO ONCOLOGY THERAPEUTICS IN | BBOT | 0.040% | ||
| 149 | Contra Akero Therapeut Common Stock | - | 0.010% | ||
| 150 | Ping An Insu Ran Ce Group Co. Of C Hin A Ltd. | 601318:SH | 0.010% | ||
| 151 | Contra Inhibrx Inc | - | 0.010% | ||
| 152 | Contra Verve Therapeut | - | 0.010% | ||
| 153 | Omniab Inc 12.5 Earnout | OABI | 0.000% | ||
| 154 | Omniab Inc 15.00 Earnout | OABI | 0.000% | ||
| 155 | us dollar001/00/1900 | - | 0.000% | ||
| 156 | Contra Blueprint Medic | - | 0.000% |











































